Physician profile
John Bouldin
NPI 1386624930
$1,828.52
in general payments reported to CMS, 2019-2025
16 companies · $130 in 2025
The $130 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2020: $84.19 · 2021: $216 · 2022: $357 · 2023: $267 · 2024: $301 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $697.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $327.33 | 2019-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Pfizer INC. | $264.51 | 2019-2023 | |
| Corium, LLC | $246.47 | 2022-2024 | Azstarys |
| Glaxosmithkline, LLC. | $192.96 | 2019-2025 | Bexsero |
| Sobi, INC | $151.87 | 2019-2023 | |
| Ironshore Pharmaceuticals INC. | $133.27 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $130.59 | 2019-2022 | |
| Sanofi Pasteur INC. | $101.85 | 2019-2025 | |
| Tactile Systems Technology INC | $56.18 | 2022 | |
| Shire North American Group INC | $52.60 | 2019 | |
| Collegium Pharmaceutical, INC. | $51.34 | 2025 | Jornay Pm |
| Arbor Pharmaceuticals, INC. | $48.50 | 2019-2020 | |
| Abbvie INC. | $21.22 | 2022 | |
| Novartis Pharmaceuticals Corporation | $20.04 | 2019 | |
| Hologic Sales and Service, LLC | $15.70 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $14.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bouldin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.